Eugenol-Functionalized Bovine Bone Substitutes for Potential Osteogenic Applications
- 1University of Sharjah , , ,
- 2Vellore Institute of Technology , , ,
Abstract
The study explored the role of eugenol-functionalized bovine bone substitutes in mitigating oxidative stress and promoting osteogenesis in vitro. Bovine bones were subjected to decellularization employing physicochemical and enzymatic procedures to prepare decellularized bovine bone scaffolds (DCC). Eugenol-chitosan functionalized DCC (ECF-DCC) bone substitutes were fabricated by ball-milling DCC scaffolds, spray-drying eugenol-chitosan particulates, integrating β-TCP, and lyophilizing the homogenized composites. ECF-DCC were comprehensively assessed by SEM-EDS, RAMAN spectroscopy, and osteoblast-based viability, apoptosis, reactive oxygen species (ROS) generation, osteogenic differentiation [alkaline phosphatase (ALP), mineralization], real-time PCR, and Western blotting. RAMAN spectroscopy confirmed successful eugenol functionalization of DCC substitutes, evidenced by characteristic aromatic C═C and C–O vibrational peaks alongside preserved phosphate signatures. SEM–EDS revealed rough substitutes in 500–750 μm size with comparable elemental profiles. hFOB 1.19 cells were viable across all concentrations, with no significant increase in apoptosis, although a low-level necrosis was observed at 1000 μg/mL. ECF-DCC significantly reduced ROS generation compared to DCC. Gene expression analysis showed that ECF-DCC markedly reduced key proinflammatory cytokines including IL-6, IL-1β, and TNF-α. Both formulations enhanced osteogenic differentiation, with ECF-DCC inducing superior upregulation of RUNX2, OC, Col1, and BMP-7 at mRNA and protein levels. ECF-DCC substitutes also showed highest ALP activity and calcium mineralization, confirming their enhanced osteoinductive potential. Eugenol-chitosan functionalization enhanced the biological performance of DCC substitutes by reducing oxidative stress and inflammatory responses while significantly promoting osteogenic differentiation, highlighting potential use as improved osteoinductive bone substitutes.
Related
- Experimental and computational analysis of the nonlinear optical responses of styrylquinoline-functionalized polymers for optoelectronic applications
- Direct Assembly of a Fully Functionalized-Fragment Library for Photoaffinity Labeling Applications via Mild A³‑Coupling in Water.
- Recent advances in functionalized electrospun nanofibers for biomedical and therapeutic applications: A comprehensive review
- Multifunctional Antibacterial Nanocomposites Based on Graphene Oxide, Graphitic Carbon Nitride, and Cobalt Ferrite Functionalized with an Antimicrobial Polymer Blend and Silver Nanoparticles for Biomedical and Environmental Applications
- Dual-Functionalized Electrospun PCL Membranes with Polydopamine/Gold Nanoparticles: Cytocompatibility Assessment for a Potential Cardiac Patch
BibTeX
@article{rani2026eugenolfunctionalized,
title = {{Eugenol-Functionalized Bovine Bone Substitutes for Potential Osteogenic Applications}},
author = {K. G. Aghila Rani and Vellore Kannan Gopinath and Savitha Suresh and Ali Al Qabbani and Sausan Al Kawas and Natarajan Chandrasekaran and Ab Rani Samsudin},
journal = {ACS omega},
year = {2026},
month = sep,
doi = {10.1021/acsomega.6c06432},
url = {https://europepmc.org/article/PMC/PMC13670797},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Eugenol-Functionalized Bovine Bone Substitutes for Potential Osteogenic Applications
AU - K. G. Aghila Rani
AU - Vellore Kannan Gopinath
AU - Savitha Suresh
AU - Ali Al Qabbani
AU - Sausan Al Kawas
AU - Natarajan Chandrasekaran
AU - Ab Rani Samsudin
PY - 2026
DA - 2026/09/30
JO - ACS omega
DO - 10.1021/acsomega.6c06432
UR - https://europepmc.org/article/PMC/PMC13670797
AB - The study explored the role of eugenol-functionalized bovine bone substitutes in mitigating oxidative stress and promoting osteogenesis in vitro. Bovine bones were subjected to decellularization employing physicochemical and enzymatic procedures to prepare decellularized bovine bone scaffolds (DCC). Eugenol-chitosan functionalized DCC (ECF-DCC) bone substitutes were fabricated by ball-milling DCC scaffolds, spray-drying eugenol-chitosan particulates, integrating β-TCP, and lyophilizing the homogenized composites. ECF-DCC were comprehensively assessed by SEM-EDS, RAMAN spectroscopy, and osteoblast-based viability, apoptosis, reactive oxygen species (ROS) generation, osteogenic differentiation [alkaline phosphatase (ALP), mineralization], real-time PCR, and Western blotting. RAMAN spectroscopy confirmed successful eugenol functionalization of DCC substitutes, evidenced by characteristic aromatic C═C and C–O vibrational peaks alongside preserved phosphate signatures. SEM–EDS revealed rough substitutes in 500–750 μm size with comparable elemental profiles. hFOB 1.19 cells were viable across all concentrations, with no significant increase in apoptosis, although a low-level necrosis was observed at 1000 μg/mL. ECF-DCC significantly reduced ROS generation compared to DCC. Gene expression analysis showed that ECF-DCC markedly reduced key proinflammatory cytokines including IL-6, IL-1β, and TNF-α. Both formulations enhanced osteogenic differentiation, with ECF-DCC inducing superior upregulation of RUNX2, OC, Col1, and BMP-7 at mRNA and protein levels. ECF-DCC substitutes also showed highest ALP activity and calcium mineralization, confirming their enhanced osteoinductive potential. Eugenol-chitosan functionalization enhanced the biological performance of DCC substitutes by reducing oxidative stress and inflammatory responses while significantly promoting osteogenic differentiation, highlighting potential use as improved osteoinductive bone substitutes.
SN - 2470-1343
ER -